PROCEPT BioRobotics Corporation Increase (Decrease) in Inventories
PROCEPT BioRobotics Corporation (PRCT) reported Increase (Decrease) in Inventories of $6.83 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-05
- PROCEPT BioRobotics Corporation increase (decrease) in inventories for the quarter ending 2026-06-30 was -$199.00K, a 104.16% decline year-over-year.
- PROCEPT BioRobotics Corporation increase (decrease) in inventories for the quarter ending 2026-03-31 was $7.03M, a 11.86% increase year-over-year.
- PROCEPT BioRobotics Corporation increase (decrease) in inventories for the quarter ending 2025-12-31 was $4.00M, a 31.03% decline year-over-year.
- PROCEPT BioRobotics Corporation increase (decrease) in inventories for the quarter ending 2025-09-30 was -$568.00K, a 107.94% decline year-over-year.
- PROCEPT BioRobotics Corporation increase (decrease) in inventories for fiscal 2025 was $14.50M, a 15.88% decline from fiscal 2024.
- PROCEPT BioRobotics Corporation increase (decrease) in inventories for fiscal 2024 was $17.23M, a 76.75% increase from fiscal 2023.
- PROCEPT BioRobotics Corporation increase (decrease) in inventories for fiscal 2023 was $9.75M, a 36.06% decline from fiscal 2022.
- PROCEPT BioRobotics Corporation increase (decrease) in inventories for fiscal 2022 was $15.25M, a 149.04% increase from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$199.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $6.83M 10-Q · filed 2026-08-05 | $10.83M derived: sum of 3 quarters · filed 2026-08-05 | $10.26M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $7.03M 10-Q · filed 2026-04-30 | $11.03M derived: sum of 2 quarters · filed 2026-04-30 | $10.46M derived: sum of 3 quarters · filed 2026-04-30 | $15.24M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.43M derived: sum of 2 quarters · filed 2026-02-26 | $8.22M derived: sum of 3 quarters · filed 2026-08-05 | $14.50M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$568.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $4.22M derived: sum of 2 quarters · filed 2026-08-05 | $10.50M 10-Q · filed 2025-11-05 | $16.30M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $4.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $11.07M 10-Q · filed 2026-08-05 | $16.86M derived: sum of 3 quarters · filed 2026-08-05 | $24.02M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $6.28M 10-Q · filed 2026-04-30 | $12.08M derived: sum of 2 quarters · filed 2026-04-30 | $19.24M derived: sum of 3 quarters · filed 2026-04-30 | $22.03M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $5.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $12.96M derived: sum of 2 quarters · filed 2026-02-26 | $15.75M derived: sum of 3 quarters · filed 2026-02-26 | $17.23M 10-K · filed 2026-02-26 |
| 2024-09-30 | $7.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $9.95M derived: sum of 2 quarters · filed 2025-11-05 | $11.44M 10-Q · filed 2025-11-05 | $8.25M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $2.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $4.28M 10-Q · filed 2025-08-07 | $1.09M derived: sum of 3 quarters · filed 2026-02-26 | $609.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $1.49M 10-Q · filed 2025-05-02 | -$1.70M derived: sum of 2 quarters · filed 2026-02-26 | -$2.19M derived: sum of 3 quarters · filed 2026-02-26 | $1.10M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$3.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$3.67M derived: sum of 2 quarters · filed 2026-02-26 | -$385.00K derived: sum of 3 quarters · filed 2026-02-26 | $9.75M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$485.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-28 | $2.80M derived: sum of 2 quarters · filed 2024-10-28 | $12.94M 10-Q · filed 2024-10-28 | $18.69M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $3.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $13.42M 10-Q · filed 2024-08-02 | $19.17M derived: sum of 3 quarters · filed 2025-02-27 | $27.99M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $10.14M 10-Q · filed 2024-05-02 | $15.88M derived: sum of 2 quarters · filed 2025-02-27 | $24.70M derived: sum of 3 quarters · filed 2025-02-27 | $25.90M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $5.75M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $14.57M derived: sum of 2 quarters · filed 2025-02-27 | $15.77M derived: sum of 3 quarters · filed 2025-02-27 | $15.25M 10-K · filed 2025-02-27 |
| 2022-09-30 | $8.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $10.02M derived: sum of 2 quarters · filed 2023-11-02 | $9.50M 10-Q · filed 2023-11-02 | $12.05M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $684.00K 10-Q · filed 2023-07-28 | $3.23M derived: sum of 3 quarters · filed 2024-02-28 | $4.05M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$517.00K 10-Q · filed 2023-05-04 | $2.03M derived: sum of 2 quarters · filed 2024-02-28 | $2.85M derived: sum of 3 quarters · filed 2024-02-28 | $4.68M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $3.36M derived: sum of 2 quarters · filed 2024-02-28 | $5.20M derived: sum of 3 quarters · filed 2024-02-28 | $6.12M 10-K · filed 2024-02-28 |
| 2021-09-30 | $819.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $2.65M derived: sum of 2 quarters · filed 2022-11-04 | $3.58M 10-Q · filed 2022-11-04 | $5.79M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $1.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $2.76M 10-Q · filed 2022-08-05 | $4.97M derived: sum of 3 quarters · filed 2022-08-05 | |
| 2021-03-31 | $926.00K 10-Q · filed 2022-05-06 | $3.14M derived: sum of 2 quarters · filed 2022-05-06 | ||
| 2020-12-31 | $2.21M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $3.10M 10-K · filed 2022-03-22 | ||
| 2020-09-30 | $895.00K 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |